Gupta A, Arora G, Rosen C, Kloos Z, Cao Y, cerny J
PLoS Pathog. 2020; 16(11):e1009030.
PMID: 33175909
PMC: 7657531.
DOI: 10.1371/journal.ppat.1009030.
Kobayashi K, Jokaji R, Miyazawa-Hira M, Takatsuka S, Tanaka A, Ooi K
Mol Med Rep. 2017; 16(3):3147-3154.
PMID: 28714016
PMC: 5548023.
DOI: 10.3892/mmr.2017.7012.
Bernard Q, Wang Z, Di Nardo A, Boulanger N
Parasit Vectors. 2017; 10(1):313.
PMID: 28655322
PMC: 5488306.
DOI: 10.1186/s13071-017-2243-0.
Van Laar T, Hole C, Karna S, Miller C, Reddick R, Wormley F
Microbes Infect. 2016; 18(6):430-435.
PMID: 26993029
PMC: 4975942.
DOI: 10.1016/j.micinf.2016.03.004.
Small C, Ajithdoss D, Hoffmann A, Mwangi W, Esteve-Gassent M
PLoS One. 2014; 9(2):e88245.
PMID: 24505447
PMC: 3914939.
DOI: 10.1371/journal.pone.0088245.
Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice.
Gautam A, Dixit S, Embers M, Gautam R, Philipp M, Singh S
PLoS One. 2012; 7(9):e43860.
PMID: 23024745
PMC: 3443101.
DOI: 10.1371/journal.pone.0043860.
Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.
Sonderegger F, Ma Y, Maylor-Hagan H, Brewster J, Huang X, Spangrude G
J Immunol. 2011; 188(3):1381-93.
PMID: 22180617
PMC: 3262892.
DOI: 10.4049/jimmunol.1102359.
The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.
Ghose P, Ali A, Fang R, Forbes D, Ballard B, Ismail N
J Immunol. 2011; 187(3):1333-46.
PMID: 21715688
PMC: 3140540.
DOI: 10.4049/jimmunol.1100092.
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.
Zhang X, Goel T, Goodfield L, Muse S, Harvill E
J Immunol. 2011; 186(8):4895-904.
PMID: 21398615
PMC: 3618952.
DOI: 10.4049/jimmunol.1000594.
Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.
Blaho V, Buczynski M, Dennis E, Brown C
J Immunol. 2009; 183(9):5644-53.
PMID: 19843949
PMC: 2857380.
DOI: 10.4049/jimmunol.0901499.
The role of infections in autoimmune disease.
Ercolini A, Miller S
Clin Exp Immunol. 2008; 155(1):1-15.
PMID: 19076824
PMC: 2665673.
DOI: 10.1111/j.1365-2249.2008.03834.x.
Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
Ekerfelt C, Andersson M, Olausson A, Bergstrom S, Hultman P
Clin Exp Immunol. 2007; 150(1):189-97.
PMID: 17672870
PMC: 2219278.
DOI: 10.1111/j.1365-2249.2007.03474.x.
Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.
Peterson S, Nardelli D, Warner T, Callister S, Torrealba J, Schell R
Clin Vaccine Immunol. 2007; 14(5):510-7.
PMID: 17360856
PMC: 1865634.
DOI: 10.1128/CVI.00005-07.
Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut.
Steere A
Wien Klin Wochenschr. 2006; 118(21-22):625-33.
PMID: 17160599
DOI: 10.1007/s00508-006-0687-x.
Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
Munson E, Nardelli D, Luk K, Remington M, Callister S, Schell R
Clin Vaccine Immunol. 2006; 13(1):19-25.
PMID: 16425995
PMC: 1356618.
DOI: 10.1128/CVI.13.1.19-25.2006.
Dose-dependent induction of IL-6 by plant-derived proteases in vitro.
Rose B, Herder C, Loffler H, Meierhoff G, Schloot N, Walz M
Clin Exp Immunol. 2005; 143(1):85-92.
PMID: 16367938
PMC: 1809566.
DOI: 10.1111/j.1365-2249.2005.02970.x.
Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells.
Brown C, Blaho V, Loiacono C
Infect Immun. 2004; 72(9):4956-65.
PMID: 15321987
PMC: 517421.
DOI: 10.1128/IAI.72.9.4956-4965.2004.
Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y
J Clin Invest. 2004; 114(4):582-8.
PMID: 15314695
PMC: 503774.
DOI: 10.1172/JCI21795.
The emergence of Lyme disease.
Steere A, Coburn J, Glickstein L
J Clin Invest. 2004; 113(8):1093-101.
PMID: 15085185
PMC: 385417.
DOI: 10.1172/JCI21681.
Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis.
Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J
Immunology. 2002; 107(1):46-55.
PMID: 12225362
PMC: 1782772.
DOI: 10.1046/j.1365-2567.2002.01500.x.